The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-infiltrating lymphocytes in biallelic-CDK12 mutated prostate cancer.
 
Maialen Barrero
No Relationships to Disclose
 
Mattia Rediti
No Relationships to Disclose
 
Mateus Crespo
No Relationships to Disclose
 
David Dolling
No Relationships to Disclose
 
Pasquale Rescigno
No Relationships to Disclose
 
Carlo Messina
No Relationships to Disclose
 
Robert Chandler
No Relationships to Disclose
 
Diletta Bianchini
Speakers' Bureau - Janssen
 
Antonella Petremolo
No Relationships to Disclose
 
Ruth Riisnaes
No Relationships to Disclose
 
Ana Ferreira
No Relationships to Disclose
 
Daniel Nava Rodrigues
No Relationships to Disclose
 
Claudia Bertan
No Relationships to Disclose
 
Adam Sharp
No Relationships to Disclose
 
Semini Sumanasuriya
No Relationships to Disclose
 
Alec Paschalis
No Relationships to Disclose
 
Nina Tunariu
No Relationships to Disclose
 
Joaquin Mateo
Travel, Accommodations, Expenses - AstraZeneca; Sanofi
 
Suzanne Carreira
No Relationships to Disclose
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex